New Study Shows Probiotic Strain Effective in Improving Irritable Bowel Syndrom...( Bacillus coagulans significantly redu...),Health

Bacillus coagulans significantly reduces abdominal pain and bloating

CLEVELAND, March 24 /PRNewswire/ -- A new study published in the March issue of Postgraduate Medicine found that a strain of probiotic bacteria, Bacillus coagulans GBI-30, PTA-6086 was effective in relieving abdominal pain and bloating in subjects with irritable bowel syndrome (IBS). As many as 25 percent of the U.S. population suffer from IBS, a condition characterized by a number of uncomfortable digestive symptoms and associated with a severe reduction in quality of life. Although there are two prescription drugs for IBS, doctors are limited as to the solutions they can recommend. The new study adds to the growing body of evidence that certain probiotics can help with IBS and provides hope for IBS sufferers of a new option.

(Photo: http://www.newscom.com/cgi-bin/prnh/20090324/CL88141 )

(Logo: http://www.newscom.com/cgi-bin/prnh/20041213/CLM031LOGO )

The study found that subjects taking the Bacillus coagulans probiotic strain, trademarked GanedenBC30 and marketed in the over-the-counter product, Digestive Advantage Irritable Bowel Syndrome, experienced statistically significant reductions in abdominal pain and bloating versus baseline at each of the weekly measurements taken throughout the 8-week study. Subjects taking placebo experienced statistically significant reduction
'/>"/>